|
Mean age
|
58.4 (range 44–77)
|
|---|
| | | |
N = 25
|
%
|
|
Sex
|
Male
|
17
|
68
|
| |
Female
|
8
|
32
|
|
TNM Stage
|
T
|
X
|
4
|
16
|
| | |
0
|
0
|
0
|
| | |
1
|
4
|
10
|
| | |
2
|
7
|
28
|
| | |
3
|
7
|
28
|
| | |
4
|
3
|
12
|
| |
N
|
X
|
0
|
0
|
| | |
0
|
18
|
72
|
| | |
1
|
0
|
0
|
| | |
2
|
7
|
28
|
| |
M
|
0
|
0
|
0
|
| | |
1
|
25
|
100
|
|
Histology
|
Clear cell
|
21
|
84
| |
| |
Papillary
|
4
|
16
| |
|
Sites of disease
|
Lung
|
16
|
64
| |
| |
Lymph node
|
9
|
36
| |
| |
Soft tissue
|
7
|
28
| |
| |
Bone
|
6
|
24
| |
| |
Kidney
|
5
|
20
| |
| |
Liver
|
5
|
20
| |
| |
Pancreas
|
2
|
8
| |
| |
Adrenal
|
1
|
4
| |
|
Prior Therapy
|
Nephrectomy
|
23
|
92
| |
| |
Chemotherapy
|
8
|
32
| |
| |
Immunotherapy
|
10
|
40
| |
| |
Radiation therapy
|
2
|
8
| |
| |
Cryoablation
|
1
|
4
| |
| |
Laser ablation
|
1
|
4
| |
|
Treatment Characteristics
|
|
Vaccination
|
≤ 2
|
3
|
12
| |
| |
3–5
|
14
|
56
| |
| |
≥ 6
|
8
|
32
| |
|
No. of IL-2 Cycles
|
1
|
4
|
16
| |
| |
2
|
9
|
36
| |
| |
3
|
0
|
0
| |
| |
4
|
9
|
36
| |
